Manifestazioni extraintestinali della malattia di Crohn. Fattori di rischio e impatto della chirurgia digestiva

25.00

COD: 293-298 Categorie: ,

Riccardo Nascimbeni*, Francesco Di Fabio*, Alberto Lanzini**, Francesco Lanzarotto, Chiara Ricci, Claudio Casella, Bruno Salerni

Ann. Ital. Chir., 2009; 80: 293-298

La mia nuova descrizione qui!

Price of a print issue €25.00

BACKGROUND: Extraintestinal manifestations significantly affect the quality of life of patients with Crohn’s disease. The
aim of the present study is to define the risk factors for extraintestinal manifestations and the relative influence of intestinal
surgery.
PATIENTS AND METHODS: In a cohort of 223 patients with Crohn’s disease we analyzed the association between demographic/
clinico-pathological factors and extraintestinal manifestations. In addition, we evaluated their association with the
timing of appearance of the extraintestinal manifestations with respect to the intestinal surgery.
RESULTS: Fifty-seven patients (25.6%) developed 91 extraintestinal manifestations.
Demographic and clinico-pathological variables significantly associated with extraintestinal manifestations were: female
gender (OR 2.84, 95% CI: 1.37-5.90) and colonic involvement (OR 2.68, 95% CI: 1.06-6.76). In patients not undergoing
surgery and in patients with extraintestinal manifestations present only before surgery, the latency period between
the onset of Crohn’s disease and extraintestinal manifestations were 3.7 ± 8.2 and 2.1 ± 6.3 years, respectively. In
patients developed extraintestinal manifestations only after surgery, the latency between surgery and extraintestinal manifestations
was 12.0 ± 10.0 years. In 5 patients with early onset of extraintestinal manifestations, these did not regress
or recur after surgery.
CONCLUSION: Female gender and colonic involvement are confirmed as risk factors for the development of extraintestinal
manifestations in Crohn’s disease. Surgical treatment of the intestinal disease represents a therapeutic option for patients
with extraintestinal manifestations, as it seems to prevent or delay these manifestations in most cases.

0

Utilizzando il sito, accetti l'utilizzo dei cookie da parte nostra. maggiori informazioni

Questo sito utilizza i cookie per fornire la migliore esperienza di navigazione possibile. Continuando a utilizzare questo sito senza modificare le impostazioni dei cookie o cliccando su "Accetta" permetti il loro utilizzo.

Chiudi